Medifast (MED) Stock Price, News & Analysis

Company Overview

Medifast, Inc. is a health and wellness company that provides weight-management and healthy-living products and services. Its primary brand, OPTAVIA, offers meal replacements, snacks, supplements and other nutrition products designed to support structured weight-management programs.

The company’s programs combine nutrition products with guidance from independent OPTAVIA Coaches. These coaches provide accountability, support and lifestyle guidance intended to help clients develop healthier eating and activity habits.

Medifast was founded in 1980 and is headquartered in Baltimore, Maryland. The company primarily serves customers in the United States through its direct-to-consumer business model and network of independent coaches.

Key Stats

• Today's Range: $12.12 to $12.15
• 50-Day Range: $11.30 to $12.66
• 52-Week Range: $9.22 to $13.58
• Volume: 1,153 shs
• Average Volume: 209,486 shs
• Market Capitalization: $135.79 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $12.00
• Consensus Rating: Hold

Medifast Stock Analysis - MarketRank™

Medifast scored higher than 42% of companies evaluated by MarketBeat, and ranked 122nd out of 167 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.6 / 5
• Analyst Rating: Hold

Consensus Rating

Medifast has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 strong buy rating, no buy ratings, 1 hold rating, and 1 sell rating.

Upside/Downside

The consensus price target for Medifast is close to its current price, suggesting limited near-term upside or downside.

Amount of Analyst Coverage

Medifast has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Medifast are expected to grow in the coming year, from ($1.04) to ($0.47) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Medifast is -5.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Medifast is -5.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Medifast has a P/B Ratio of 0.67. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

9.78% of the float of Medifast has been sold short.

Short Interest Ratio / Days to Cover

Medifast has a short interest ratio ("days to cover") of 7.3.

Change versus previous month

Short interest in Medifast has recently decreased by 43.44%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: Weak

Dividend Yield

Medifast does not currently pay a dividend.

Dividend Growth

Medifast does not have a long track record of dividend growth.

News and Social Media

• Score: 2.9 / 5
• News Sentiment: 0.61

News Sentiment

Medifast has a news sentiment score of 0.61. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Consumer Staples companies.

News Coverage This Week

MarketBeat has tracked 8 news articles for Medifast this week, compared to 3 articles on an average week.

MarketBeat Follows

1 people have added Medifast to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 3.7 / 5
• Insider Trading: Acquiring Shares

Net Insider Buying

Over the last three months, insiders have purchased a net $1,197,276.00 in company stock, which represents 0.8848% of the company's market cap.

Insider Buying vs. Insider Selling

In the past three months, Medifast insiders have bought 529.07% more of their company's stock than they have sold. Specifically, they have bought $1,423,576.00 in company stock and sold $226,300.00 in company stock.

Percentage Held by Insiders

3.70% of the stock of Medifast is held by insiders.

Percentage Held by Institutions

95.51% of the stock of Medifast is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/03/2026
• Today: 10/16/2026
• Next Earnings (Confirmed): 10/26/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Consumer Staples
• Industry: Personal Care Products
• Sub-Industry: Personal Care Products
• Current Symbol: NYSE:MED
• CIK: 910329
• Web: www.medifastinc.com
• Phone: (410) 581-8042
• Fax: 410-581-8070
• Employees: 380
• Year Founded: 1981

Price Target and Rating

• Average Price Target for Medifast: $12.00
• High Price Target: $12.00
• Low Price Target: $12.00
• Potential Upside/Downside: -1.2%
• Consensus Rating: Hold
• Rating Score (0-4): 2.33
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): ($2.33)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$18.67 million
• Net Margins: -8.08%
• Pretax Margin: -4.41%
• Return on Equity: -6.69%
• Return on Assets: -5.25%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 4.86
• Quick Ratio: 4.35

Sales & Book Value

• Annual Sales: $316.93 million
• Price / Sales: 0.43
• Cash Flow: $0.43 per share
• Price / Cash Flow: 28.55
• Book Value: $18.10 per share
• Price / Book: 0.67

Miscellaneous

• Outstanding Shares: 11,181,000
• Free Float: 10,767,000
• Market Cap: $135.79 million
• Optionable: Optionable
• Beta: 0.68